Veru Inc.: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value
Free cash flow over the last three years averaged below zero, so a cash-flow value cannot be worked out.
Your own DCF model
A full discounted-cash-flow model of Veru Inc., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the industry Biotechnology
Multiples of its companies with a market value at most 60 days old, times Veru Inc.'s own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Veru Inc. | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| Price to book | 3.1× / 4.5× / 12.9× | 2.3× | book equity $18 M | $56 M to $236 M | 69 |
Against its own history
Veru Inc.'s multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.
Price to sales
5.0×Now below its median of 6.3×, in the bottom quarter of its range; range 2.8× to 14.1× over 9 months.
Price to book
2.3×Now below its median of 2.3×; range 1.1× to 19.9× over 30 months.
As of Oct 9, 2026
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to Sep 30, 2025 | — | $-23 M | $-30 M | $0 M | $-30 M | — | SEC annual report (10-K, 20-F) |
| FY2024to Sep 30, 2024 | $17 M | $-38 M | $-22 M | $0 M | $-22 M | — | SEC annual report (10-K, 20-F) |
| FY2023to Sep 30, 2023 | $16 M | $-93 M | $-88 M | $1 M | $-89 M | — | SEC annual report (10-K, 20-F) |
| FY2022to Sep 30, 2022 | $39 M | $-84 M | $-48 M | $1 M | $-48 M | — | SEC annual report (10-K, 20-F) |
| FY2021to Sep 30, 2021 | $61 M | $7 M | $-16 M | $0 M | $-16 M | — | SEC annual report (10-K, 20-F) |
| FY2020to Sep 30, 2020 | $43 M | $-19 M | $-2 M | $0 M | $-2 M | — | SEC annual report (10-K, 20-F) |